News archive for The Department of Biomedicine

Trial lecture and public defence: Tor-Arne Hegvik (29.01.2019)

The candidate will give a trial lecture and defend his doctoral thesis with the title: “Attention-deficit/hyperactivity disorder and autoimmune diseases: etiological relationships and therapeutic possibilities”

New microscope ready for use (22.01.2019)

Early Stage Researcher Seminar - Tor-Arne Hegvik (21.01.2019)

Attention-deficit/hyperactivity disorder and autoimmune diseases: etiological relationships and therapeutic possibilities

Nature: A new tool to classify tumors of the central nervous system (15.01.2019)

There are over 100 tumor types only in the central nervous system. The Translational Cancer Research Group at the Department of Biomedicine provided data and material for a new diagnostic tool that will make it easier for cancer researchers to see the difference.

The Quaternary Structure of Human Tyrosine Hydroxylase (14.01.2019)

The enzyme tyrosine hydroxylase is essential for life. Neurological, psychiatric and cardiovascular disorders occur when its catalytic function is impaired. Researchers at the Department of Biomedicine describe how new insights into the protein might help develop new avenues for treatment.

EPIC-XS: Ten Million Euro for Access to European Proteomics Facilities (11.01.2019)

Thomas Arnesen and Harald Barsnes from the Department of Biomedicine are part of a new european consortium in the field of mass spectrometry based proteomics research. The European Union has awarded 10 million Euro.

Actin Modifications: Finding the Right Shoe for Cinderella (11.01.2019)

Cinderella is a tale of being lifted from obscurity to recognition and significance. A review by young researchers at the Department of Biomedicine highlights the importance of the post-translational modifications of actin.